L&K BIOMED CO., LTD. Kang Kuk-jin group holds 12.31% stake as some pledge contracts are repaid and released
AI summary · Not investment advice
Kang Kuk-jin and related parties' holding stays at 12.31% as some pledge contracts were repaid, leaving 778,359 shares under contract.
Key facts
- Stake
- 12.31%
- Reporting holder
- Kang Kuk-jin and 6 related parties
- Previous stake
- 12.31%
- Purpose of holding
- Influence on management control
- Report type
- Change
- Reason for report
- Change in some contracts concerning shares held (repayment, release)
- Previous shares held
- 2,751,168 shares
- Shares held
- 2,751,168 shares
- Reason for amendment
- Change in some contracts concerning shares held (repayment, release)
Commentary
AI commentary · Not investment advice
What happened
Kang Kuk-jin and 6 related parties holding shares of LNK Bio reported a change. Part of the contracts that put their shares up as collateral was repaid and released.
In the company's terms
The collateral contracts in Kang's name covered 400,000 shares and 378,359 shares. Of these, 369,277 shares were released. The total of the contracts now stands at 778,359 shares.
What changes for shareholders
The group's holding stayed at 2,751,168 shares, both before and after this report. The ownership stake also stayed at 12.31%. The stated purpose of the holding is to influence management control.
Earlier Report on Large Shareholdings filings from this company
| Filed | Reporting holder | Stake | Change |
|---|---|---|---|
| 26.10.162026.10.16 | Kang Gook Jin and 6 related parties | 12.31% | +0.09%p |
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
L